Purpose: The incidence of epilepsy in older adults is growing, as does the incidence of comorbidities. Therefore, when it comes to epilepsy surgery in medically intractable epilepsy, age is often seen as a limiting factor. To investigate the outcome after epilepsy surgery in a population of older adults, we compared the benefit for patients aged 50-59 years with those aged 60 years and older in respect of efficacy and safety. Method: Patients aged !50 years with medically intractable epilepsy who underwent epilepsy surgery from 1990 to 2013 were selected from the database of a German epilepsy center. All of them received a standardised and detailed presurgical diagnostic evaluation. Follow-up included at least four scheduled visits with EEG, MRI and neuropsychological testing. Outcome was assessed using the Engel outcome scale. Results: 79 patients aged between 50 and 67 years were followed-up for a median of 4.7 years (2-16 years). 68% of patients were free of disabling seizures (Engel class I, !60 years: 75%) and 58% were seizure-free (Engel class IA, !60 years: 70%). 90% of our patients suffered from temporal lobe epilepsy (TLE), 9% from frontal lobe epilepsy (FLE) and one occipital lobe epilepsy (OLE). After surgery, 9% discontinued or tapered their medication. Permanent surgical complications occurred in 10% of cases and transient neurological deficits were seen in 11%. Older patients had a higher risk for postoperative hygroma (!60 years 15%; <60 years 8%) and were more prone to postoperative memory deficits (!60 years 45%), especially after resection of the dominant temporal lobe. Verbal and figural memory testing did not differ significantly between the groups. Conclusions: The results support the view that in selected older patients, epilepsy surgery shows equal or even higher success rates as compared to younger patients. However, patients of older age may be at greater risk for postoperative hygroma and memory deficits, especially after dominant temporal lobe resections.
Introduction
People of higher age are the most rapidly growing part of the population in industrialised countries. The prevalence of epilepsy in this group exceeds those of younger ages [1, 2] . Therefore, in recent years epilepsy in later life has been brought to focus by a series of studies that addressed the similarities and differences of the epilepsies in younger and older people [3] [4] [5] . In general, epilepsy of higher age is still underreported [2] .
Overall, estimations suggest that one third of all epilepsy patients do not achieve seizure freedom through antiepileptic drugs (AED) [6, 7] . For a significant subset of drug refractory patients with focal epilepsy, epilepsy surgery has been shown to be the superior therapy over continued drug treatment [8, 9] .
In the majority of cases, new onset epilepsies in later life are symptomatic focal epilepsies which may be in part amenable to epilepsy surgery [10, 11] . In addition, due to the potentially long latency to diagnosis and reluctance for surgery some patients who were referred to our center grew old with their epilepsy. To date however, little is known about the risks and benefits of epilepsy surgery in patients of higher age, because most studies concentrate on patients under the age of 50 years [5, [12] [13] [14] [15] . In selected conditions such as hippocampal sclerosis, the efficacy and safety appear to be similar compared to younger patients [12, 13] . Nevertheless, epilepsy surgery in older adults may still follow its own characteristics due to etiological differences in this age group with higher incidence of stroke, haemorrhage and tumours and higher prevalence of comorbidities such as cardiovascular diseases [5, 16] . Despite positive reports that showed good postoperative outcome in 90% of 12 patients aged 60 years and older [17] , postoperative seizure freedom has to be balanced against the operative risks and postoperative neuropsychological deficits as well as psychiatric morbidity in this age group [18, 19] .
To better investigate the chances and risks of epilepsy surgery in patients of older age, we conducted a retrospective study on the long-term outcome of patients aged 50 years and older after epilepsy surgery at our center between 1990 and 2013.
Methods

Patients
The study cohort was identified from our database in which all patients are recorded who were seen at the Epilepsy Centre Erlangen since 1990. Inclusion criteria were !50 years of age at the time of surgery and availability of postoperative follow-up information at a minimum of two years after surgery. All patients' charts were reviewed and analysed retrospectively. Missing information was integrated from telephone interviews.
Presurgical diagnostics
All patients received a standardised presurgical diagnostic evaluation which consisted of a detailed clinical history (including epilepsy characteristics, seizure semiology and frequency, co-morbidities and medication), ictal and interictal video-EEG monitoring, 1.5-or 3-T magnetic resonance imaging (MRI) according to a standardised epilepsy protocol and a structured neuropsychological evaluation. If necessary, additional diagnostic procedures such as voxel-based morphometry, single-photon emission computed tomography, positron emission tomography, Wada test, functional MRI, magnetoencephalography or invasive EEG recordings with depth and/or subdural electrodes were amended. The surgical procedure was designed by integrating all available data and weighing chances for postoperative seizure freedom against potential risks for deficits induced by the resection. Surgical decision was made in our interdisciplinary board of epilepsy surgery.
Follow-up, outcome assessment and complications
Until 2011, the standard postoperative follow-up at our center included an outpatient visit after three months, 24 h of video-EEG monitoring, MRI and neuropsychological evaluation at six months and additional clinical follow-up visits at one, two, five and 10 years postoperative. Since 2011, the standard postoperative followup was extended to schedule additional visits at three and 20 years after surgery. In addition to the standard follow-up, many patients return to our outpatient clinics on a yearly basis. Seizure related outcome was determined through retrospective information from clinical files at the patients' most recent visit according to the Engel outcome scale [20] . Neuropsychological data were reviewed and categorised for all patients at six months after surgery and at the last available testing in the case of repeated neuropsychological tests. A combined overall score comprised all aspects of the testing and was rated by a neuropsychologist according to the relevance of any changes into the categories «better», «no change» or «worse». Further memory tests included verbal and figural memory using the Berliner Amnesietest (BAT) and the Wechsler Memory Scale (WMS). Z-Scores were calculated and differences were rated as relevant if Dz was !|AE1|. In addition, we recorded the most recent information on past and current medication, controlled for possible postoperative complications and comorbidities. In this respect, we distinguished expected and accepted deficits and transient loss of function from unexpected and persistent deficits.
Statistical analysis
This retrospective study was designed as explorative analysis. The cohort was split into the two subgroups according to age: 50-59 years (<60yrs) and patients aged 60 years and older (!60yrs). Results are given in median, total numbers, and percentage of the respective subgroup or the whole cohort and range, where appropriate. Due to the lack of a Gaussian distribution of our data, non-parametric tests were used to test group differences. For nominal and ordinal data, contingency tables and Pearson's chi square were applied. Continuous data were analysed using the Wilcoxon rank sum test. Because of the explorative nature of the study, we did not adjust for multiple testing. All p-values were interpreted as descriptive measures, rather than results of hypothesis testing. For computation, jmp 1 software (SAS institute, version 12) was used.
Results
Patients' characteristics
We included 79 patients who underwent epilepsy surgery at the age of 50-67 years, of which 30 patients (38%) were female ( Fig. 1,Table 1 ). 20 patients were 60 years or older at the time of surgery (25%, 60-67yrs) and 59 patients were between 50 and 59 years old (75%). The median age at epilepsy onset was 24 years, ranging from the earliest onset at the age of one year in the younger group to 63 years in the older group. Median epilepsy duration was 32 years, ranging between less than one to 57 years. Fig. 1 . Flow-chart on patient number and data retrieval.
Three patients were operated within one year after epilepsy diagnosis, of which two were drug-resistant with more than two adequate AED trials [7] and one patient was operated to further minimize the risk of bleeding. 71 of 79 patients (90%) suffered from temporal lobe epilepsy (TLE) which affected 93% <60 years and 80% !60 years ( Table 1 ). The majority of patients (N = 47/79, 59%) were operated on the right hemisphere, which represented the non-dominant hemisphere in most cases (N = 47/52, 90%; Table 1 ). In the older patient group about half of the patients were operated on the left hemisphere (N = 9/20, 45%; Table 1 ).
Hippocampal sclerosis and cavernoma were the most frequent histopathological diagnoses in both age groups (N = 35 and N = 17, respectively; Suppl. Table 1 ). Focal cortical dysplasia and tumours were each diagnosed in six patients. In four patients younger than 60 years the tumours were characterised as gangliogliomas (WHO grade 1) (N = 3) and one dysembryoplastic neuroepithelial tumour, and one older patient over 60 years suffered from a ganglioglioma WHO grade 1 (Suppl. Table 1 ).
Follow-up and seizure outcome
The median duration of the follow-up was 4.7 years, ranging up to 16 years (Table 1) . A 52-year-old woman who had undergone resection of a focal cortical dysplasia after invasive EEG died two months after surgery due to an out-of-hospital acquired pneumonia, thus we excluded her from further analyses of the follow-up (Fig. 1) . Two patients died 6.6 and 10.9 years after epilepsy surgery at the age of 60 and 66 due to non-cerebral cancer. Two years after surgery, 45 patients were seizure-free (Engel class IA).
Fifty-three patients were free of disabling seizures (Engel class I) and 64 patients showed a favourable postoperative outcome (Engel class I + II; Table 2 ). At the last follow-up, 51 patients remained in Engel class I ( Table 2 ). In older patients (!60yrs), 14 patients (70%) remained seizure-free until the last follow-up (Engel class IA) and 16 patients (80%) had no disabling seizures (Engel class I). In contrast, only 38% (N = 22) of our patients younger than 60 years remained seizure-free (Engel class IA) and 60% (N = 35) had no disabling seizure in the long term (Engel class I). Four years after surgery, only 53% of patients (N = 41) continued the follow-up (<60yrs: N = 28; !60yrs: N = 13). Of these patients, 16 (39%) remained seizure-free (Engel class IA: <60yrs: N = 9/28, 32%; !60yrs: N = 7/13, 54%) and 25 (61%) had no disabling seizures (Engel class I). Only four percent of all patients (N = 3) showed no improvement after surgery and none of the patients showed persistent worsening of seizures after epilepsy surgery. According to patients' charts, patients with a stable postoperative seizure outcome did not return as often to our outpatient department compared to patients who experienced an improvement of seizure frequency, although not completely seizure-free (p = 0.0016). Nevertheless, patients with a poorer outcome returned to the outpatient department for longest, especially in the case of relapsing seizures after an initial seizure-free period following surgery.
Complications and neurological deficits
Intraoperative complications occurred in three cases (4%). One 55-year-old patient suffered from a right laterally pronounced 
Number of patients in total numbers and percent of the respective age group. a Three patients were operated within one year after epilepsy diagnosis, all due to newly diagnosed cavernoma. Table 2 Seizure outcome.
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hemiparesis due to an intraoperative bleeding. Another patient aged 52 years showed a left-sided hemiparesis following a right temporal resection due to an intraoperative infarction. However, for one 67-year-old patient a monoparesis of an arm after occipital surgery occurred unexplained. Furthermore, five patients needed an additional operation during the follow-up. One 56-year-old patient suffered from wound healing disturbance with a consecutive intracranial infection, resulting in a subdural empyema, that had to be surgically revised and showed a permanent impaired verbal memory function. A 65-year-old patient needed a surgical release of a symptomatic postoperative subdural haematoma. And three patients (4%) including two at the age of 60 years and older developed a persistent hygroma which required a shunt implantation. However, in five other patients (6%) an asymptomatic hygroma was seen only radiologically and resolved without sequelae. Thus, the risk for a postoperative hygroma was higher among patients older than 60 years (<60 yrs: N = 5/59, 8%; !60 yrs: N = 3/20, 15%). In addition, transient neurological deficits were seen in four patients (5%), two of which had a facial and arm paresis and two patients showed a transient speech impediment.
No deaths occurred postoperatively.
Medication
Two years after surgery, only one 59-year-old patient had discontinued his medication whereas at the last follow-up seven patients (9%) had withdrawn the AED completely (Suppl. Table 2 ). However, two years after surgery, 15 patients (19%) were able to reduce the number of AED and 24 patients (31%) had done so at last follow-up. The majority of patients did not change their medication over the course of the follow-up (after 2yrs: N = 56/78; 72%; at the last follow-up: N = 41/78, 53%). Thirteen patients (17%) had to escalate AED dosage (after 2yrs: N = 7/78, 9%), rendering one patient seizure-free and improving seizure control in 3 other patients (Suppl. Postoperative neuropsychological testing revealed that after surgery 68% of the patients (N = 51/75) did not change in any aspect of the testing, of which two patients were considered neuropsychologically intact. In four cases the neuropsychological data were missing. Five patients (7%) improved during the follow-up in at least one aspect of the testing, while 19 patients (25%) showed poorer performance after surgery. This poorer outcome was significantly associated with surgery on the dominant hemisphere (dominant: N = 12/23, 52%; non-dominant: N = 7/50, 14%, p = 0.0063) and occurred in TLE except for one case suffering from FLE. Further subdivision of memory domains revealed that verbal memory but not figural memory function was associated with surgery on the dominant hemisphere (VM: N = 13/26, 50% p = 0.0093; FM: N = 5/26, 19%, p = 0.4145).
Decline of the overall memory function was noted more frequently in patients older than 60 years (<60yrs: N = 15/59, 25%; !60yrs: N = 9/20, 45%, p = 0.2419) with a significant difference only among patients who underwent surgery on the dominant hemisphere in both subgroups (<60yrs: N = 10/19, 53%, p < 0.0001; !60yrs: N = 6/8, 75%, p = 0.0014). When we further divided memory function into VM and FM we found the higher frequency of decline in the older patient group confirmed (VM: p = 0.2525; FM: p = 0.0696; Table 3 . Compared to the 6 months follow-up in VM four patients experienced no relevant change and two experienced an improvement. However, two in patients VM function decreased relevantly due to a subdural empyema and a psychological disorder. In FM three patients each experienced a relevant improvement and no change, while one patient faced a relevant decline due to a schizoid personality disorder. No patient older than 60 years was re-tested during the course of the follow-up. However, transient neuropsychological impairment occurred in 13 patients in the form of depression, avolition or loss of concentration. In particular, depression occurred more frequent in the younger patient group (<60yrs: 24%; !60yrs: 15%).
Invasive EEG monitoring
Thirteen of 79 patients (16%) received invasive EEG recordings during their presurgical evaluation (subdural electrodes N = 8/79, 10%; SEEG N = 3/79, 4%; foramen ovale electrodes N = 4/79, 5%) and ten patients (13%) received intraoperative electrocorticography (ECoG). Patients who received invasive EEG recordings suffered from frontal (N = 4/13, 31%) or temporal epilepsy (N = 9/13, 69%). Ten of these patients achieved a favourable outcome (Engel class I + II, N = 10/13, 77%) of which almost a third (N = 4/13, 31%) was free of disabling seizures (Engel class I) and three patients were completely seizure-free (Engel class IA) at the last follow-up. In the older patient group, three were implanted with subdural electrodes of which two were completely seizurefree (Engel class IA) and one showed a favourable outcome (Engel class IIB) and three others underwent intraoperative ECoG. Of these patients, five improved significantly over the course of the follow-up (Engel class I N = 4, class II N = 1) only one showed a decrease seizure control after surgery including ECoG (Engel class 4A). Verbal and figural memory function of both patient groups six months after surgery. Dz was considered relevant if the difference of pre-and postoperative scores amounted to Dz ! | AE 1|. Dz: !1 = relevant improvement; À1 < Dz < 1 = no change/identical; À1 = relevant decline. Although a decline in both memory domains was observed more frequently in the older patient group (*), no significant differences existed between the groups.
Thus, the majority of patients who received an invasive EEG had a favourable seizure outcome, particularly in the older patient group (Engel class I + II, all: N = 10/13, 77%; <60yrs: N = 7/10, 70%; !60yrs: N = 3/3, 100%). Including ECoG, most patients benefited from a presurgical invasive or intraoperative recording (Engel class I + II, <60yrs: N = 12/15, 80%; !60yrs: N = 5/6, 83%). However, compared to patients who did not receive an invasive EEG there was no difference in terms of a significantly better seizure outcome (Engel class I + II, <60yrs: N = 35/43, 81%; !60yrs: 12/14, 85%).
One patient who received subdural electrodes suffered from a chronic subdural haematoma after surgery, that had to be surgically revised.
Discussion
The results of this study support the view that epilepsy surgery can be a promising therapeutic option for patients of older age who suffer from focal drug-resistant epilepsy (DRE), even beyond 60 years and despite a long duration before surgery. Epilepsy syndromes and aetiology did not differ significantly between the two age groups, and 90% of all patients suffered from TLE, which is the most common cause for DRE and epilepsy surgery [8, 9, 21, 22] . Postoperative histopathology revealed most of all hippocampal sclerosis [22, 23] , as well as cavernoma, focal cortical dysplasia [24] and tumour [25] . In the majority of cases, patients were operated on the non-dominant hemisphere. The preference of the non-dominant, usually the right hemisphere, and of lesional epilepsy syndromes over non-lesional cases is a common finding in the selection of patients of all age groups for resective epilepsy surgery [22] .
Despite three patients with newly diagnosed cavernoma who were scheduled for surgery soon after epilepsy onset, our patients showed a median epilepsy duration of 32 years until surgery which is similar to other studies [5, 8, 13, 16, 26] .
The complication rate we found in our study was ten percent of permanent complications, which is similar to another large series of older patients [5] , but compares to three percent in younger patient cohorts [27, 28] . However, among these ten percent three patients (4%) had intraoperative complications. The other five patients (6%) needed an additional surgical procedure due to postoperative complications (1 empyema, 1 subdural haemorrhage and 3 hygroma). Transient complications occurred in 11% of patients, of which five patients (6%) had an asymptomatic only radiologically diagnosed hygroma which resolved without sequelae and four patients (5%) showed transient neurological deficits. In large series of younger patients 7.5-8.9% of minor complications have been reported [27, 28] . Thus, our results confirm previously reported complication rates in patients of higher age [5] and are in line with reports of a favourable outcome (Engel class I + II) also in patients older than 50 years [13] . Nevertheless, the risk for a postoperative hygroma was higher among patients older than 60 years (N = 3/20) of which two were permanent and needed a shunt implantation. This higher risk for postoperative hygroma might be explained by age-dependant brain atrophy in those patients. Above that, no other age-specific complications in our older patients could be found, that did not occur in younger patients as well. No patient died during or related to surgery.
Two years after epilepsy surgery, 82% of our patients showed a favourable outcome (Engel class I + II), 68% were free of disabling seizures (Engel class I) and more than half of all patients (58%) remained seizure-free (Engel class IA, Table 2 ). As expected, the share of patients with excellent seizure outcome decreased over time, but still after a median follow-up of 4.7 years, about two thirds (65%) of all patients were free of disabling seizures (Engel class I) and 46% remained seizure-free (Engel class IA). While 38% of patients under 60 years showed long-term seizure-freedom, this was the case in 70% of patients older than 60 years (Engel class IA). Compared to a review on the long-term seizure outcome in patients of different age, this result is above the reported median proportion of seizure-free patients [9] and compares to the results of another study that found no difference compared to patients younger than 50 years [5] . Yet, among patients aged 60 years and older, the median follow-up time was even longer (!60yrs: 5.2yrs). The discrepancy may reflect the tendency towards operating clearcut cases at higher age, balancing the chance of a seizure-free outcome against concerns about complications because of comorbidities, more frail conditions with lower capacity for recovery and a higher risk for potential cardiac and pulmonary complications [5, 21, 29] . Our results are therefore in contrast with another study, that reported a poorer postoperative outcome for higher age [30] . Only a few studies focus on the efficacy of epilepsy surgery in older patients and especially in those aged 60 years and beyond [5, 12, 17] . Available data are in line with our results and suggest that older patients can expect the same chance for excellent seizure control as compared to younger patients [26] . Still, most studies report on short-term outcome of small patient groups. Therefore, little is known about long-term seizure outcome after epilepsy surgery in general and in particular in older patients [26, [31] [32] [33] . Our data clearly indicate a long-term benefit in focal DRE in older patients undergoing epilepsy surgery.
However, only one patient had discontinued and 19% reduced AED two years after surgery. At the last follow-up nine percent had discontinued AED and 31% had reduced them, which might explain the relative increase of recurrent seizures after the regular followup time of two years. This is in line with a previous study in a younger patient population [31] and reflects the notion that many patients decide to continue medication to ensure seizure freedom. Although reduction of AED may be an important goal influencing quality of life regardless of age, one has to be careful in respect to not compromise beneficial outcome for convenience [34] .
About one fourth of the patients experienced postoperative neuropsychological decline, especially after resections in the dominant hemisphere [35] . A decline of memory function was observed more often in older patients (<60yrs: 22%; !60yrs: 37%), confirming previous studies [5, 18, 35] and was true for deficits of the verbal and figural memory domain. However, the association of functional decline and resections on the dominant hemisphere could only be confirmed for verbal memory. Although, in our study older patients did not show a poorer preoperative performance to start from [5] . Furthermore, postoperative neuropsychological outcome did not show significant differences when compared to patients younger than 50 years in previous studies [15] . Confounding effects for age, age at onset or surgery, duration of epilepsy and gender were not evident. Therefore, older patients may have the reduced capacity to compensate for cognitive disturbances which may put older patients at an increased risk for postoperative memory decline.
Neuropsychological testing on later visits was only available in eight patients, all of them younger than 60 years. Memory remained roughly stable during their postoperative course. Because of the small number of patients with neuropsychological long-term follow-up our data do not allow firm conclusions on the long-term neuropsychological outcome. Nevertheless, most patients in both groups did not experience a relevant change in postoperative memory function. This is in line with the findings of a recent study on a similar cohort aged 50 years and older, which did not find a significant postoperative change of neuropsychological performances either [36] . Postoperative depression, however transient in most cases, was seen more often in younger patients.
During the preoperative monitoring, 13 patients received intracranial EEG recordings. 77% of these patients achieved a favourable postoperative seizure control (Engel class I + II). Particularly patients of higher age had a favourable postoperative outcome after a presurgical invasive EEG (100% Engel class I + II, and 83% including intraoperative ECoG). At the same time the complication rate in these cases was not increased. However, patients who did not receive a presurgical invasive or intraoperative EEG showed a similar outcome at the last follow-up (85% Engel class I + II). This could be due to the fact that an additional invasive EEG was frequently indicated in more difficult cases, including lesions in the central region, supplementary motor cortex (SMA), in close proximity to eloquent cortical areas and cases with FCD or inconclusive imaging. Therefore, in summary our results indicate that invasive EEG monitoring can be a helpful and necessary diagnostic tool, also in selected older patients, and to improve the postoperative outcome in particularly difficult cases.
Limitations of our study included the small number of patients aged 60 years and older with no patient older than 67 years of age. Furthermore, the results have to be interpreted with caution, due to the retrospective design of the analyses and the absence of a younger control group, although our cohort showed similar characteristics compared to older subgroups in other studies. In addition, the long-term follow-up data was limited because 25 successfully operated epilepsy patients were lost to follow-up in the long run (Fig. 1) .
Conclusions
The findings of the current study revealed long-term benefits of epilepsy surgery in selected patients of higher age. The longer duration of epilepsy did not correlate with poorer seizure control. Invasive EEG monitoring seems to be as effective as for younger patients. The neuropsychological testing indicated that older patients may be at greater risk to suffer from postoperative memory disturbances than younger age groups, especially after dominant temporal lobe resections. The current data support the view that patients should not be bared form epilepsy surgery only because of higher age. On the contrary, epilepsy surgery in selected older patients shows an equal or may even show a higher success rate as compared to younger patients.
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